These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 33175110)

  • 21. Arguments in favour of remdesivir for treating SARS-CoV-2 infections.
    Ko WC; Rolain JM; Lee NY; Chen PL; Huang CT; Lee PI; Hsueh PR
    Int J Antimicrob Agents; 2020 Apr; 55(4):105933. PubMed ID: 32147516
    [No Abstract]   [Full Text] [Related]  

  • 22. Emergency Use Authorization for Remdesivir and Its Potential Implications.
    Ochoa Chaar CI; Makuch R
    Ther Innov Regul Sci; 2021 Mar; 55(2):270-271. PubMed ID: 32880853
    [No Abstract]   [Full Text] [Related]  

  • 23. Research shows racial disparity, mortality data for patients with cancer and COVID-19.
    Printz C
    Cancer; 2021 Feb; 127(3):333. PubMed ID: 33434336
    [No Abstract]   [Full Text] [Related]  

  • 24. A Potential Antiviral Treatment for COVID-19: Remdesivir.
    O'Malley PA
    Clin Nurse Spec; 2020; 34(6):257-260. PubMed ID: 33009111
    [No Abstract]   [Full Text] [Related]  

  • 25. Repurposing antimalarials and other drugs for COVID-19.
    Schlagenhauf P; Grobusch MP; Maier JD; Gautret P
    Travel Med Infect Dis; 2020; 34():101658. PubMed ID: 32247925
    [No Abstract]   [Full Text] [Related]  

  • 26. [Remdesivir for patients with severe COVID-19].
    Augustin M; Hallek M; Nitschmann S
    Internist (Berl); 2020 Jun; 61(6):644-645. PubMed ID: 32333086
    [No Abstract]   [Full Text] [Related]  

  • 27. Early remdesivir treatment in COVID-19: Why wait another day?
    Cubeddu LX; Cubeddu RJ
    J Med Virol; 2021 Jul; 93(7):4078-4080. PubMed ID: 33511655
    [No Abstract]   [Full Text] [Related]  

  • 28. Remdesivir: a pendulum in a pandemic.
    Schwartz IS; Heil EL; McCreary EK
    BMJ; 2020 Nov; 371():m4560. PubMed ID: 33234523
    [No Abstract]   [Full Text] [Related]  

  • 29. Scientists criticize use of unproven COVID drugs in India.
    Vaidyanathan G
    Nature; 2020 Nov; 587(7833):187-188. PubMed ID: 33169025
    [No Abstract]   [Full Text] [Related]  

  • 30. Remdesivir for patients with COVID-19.
    Wu PE; Morris AM
    CMAJ; 2021 Jan; 193(4):E125. PubMed ID: 33408097
    [No Abstract]   [Full Text] [Related]  

  • 31. Remdesivir in The Treatment of COVID-19.
    Rosenberg K
    Am J Nurs; 2021 Jan; 121(1):55. PubMed ID: 33350698
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Remdesivir for the treatment of COVID-19 in pregnancy.
    Lampejo T
    J Med Virol; 2021 Jul; 93(7):4114-4119. PubMed ID: 33788273
    [No Abstract]   [Full Text] [Related]  

  • 33. COVID-19 updates: Remdesivir (Veklury) in high-risk outpatients with COVID-19.
    Med Lett Drugs Ther; 2022 Feb; 64(1644):31-32. PubMed ID: 35171898
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical course and serial chest ultra-low-dose CT findings in a patient with COVID-19 treated with remdesivir.
    Grazioli-Gauthier L; Vanini G; Argentieri G; Bernasconi E; Gianella P
    Minerva Med; 2021 Aug; 112(4):516-518. PubMed ID: 34269015
    [No Abstract]   [Full Text] [Related]  

  • 35. Remdesivir for COVID-19 in Europe: will it provide value for money?
    Dal-RĂ© R; Banzi R; Georgin-Lavialle S; Porcher R; Sofat R; Zeitlinger M; Rosendaal FR
    Lancet Respir Med; 2021 Feb; 9(2):127-128. PubMed ID: 33341157
    [No Abstract]   [Full Text] [Related]  

  • 36. Protect Pregnant and Lactating Women with COVID-19 Through Research, Not from Research.
    Stuebe A
    Breastfeed Med; 2020 Jun; 15(6):423-424. PubMed ID: 32420755
    [No Abstract]   [Full Text] [Related]  

  • 37. Safety profile of the antiviral drug remdesivir: An update.
    Fan Q; Zhang B; Ma J; Zhang S
    Biomed Pharmacother; 2020 Oct; 130():110532. PubMed ID: 32707440
    [No Abstract]   [Full Text] [Related]  

  • 38. Global trial eliminates drugs, pivots to new ones.
    Kupferschmidt K
    Science; 2020 Oct; 370(6515):388-389. PubMed ID: 33093086
    [No Abstract]   [Full Text] [Related]  

  • 39. COVID-19 treatment combinations and associations with mortality in a large multi-site healthcare system.
    Coppock D; Baram M; Chang AM; Henwood P; Kubey A; Summer R; Zurlo J; Li M; Hess B
    PLoS One; 2021; 16(6):e0252591. PubMed ID: 34115801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2).
    Qaseem A; Yost J; Etxeandia-Ikobaltzeta I; Abraham GM; Jokela JA; Forciea MA; Miller MC; Humphrey LL; ; Centor RM; Andrews R; Haeme R
    Ann Intern Med; 2021 May; 174(5):673-679. PubMed ID: 33560862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.